Alcoa Corporation

AA Q2 2026

Reported: 2026-07-18

Alcoa’s shares fell 9.5% after the earnings release as investors reacted negatively to cautious commentary on near-term growth prospects and margin pressures hinted in the call, overshadowing stable operational execution.

Key takeaways

Primary aluminum production increased sequentially by 30 thousand metric tons, supported by restarts and strong shipments at the Alumar smelter.
The company secured multiyear labor agreements across major smelters, enhancing workforce stability through 2030.
Strategic initiatives include a $65 million capacity expansion in Norway and a new gallium production facility funded in part by government partners.
The announced acquisition of South32’s upstream aluminum assets is positioned to deliver cost synergies (~$900 million NPV) and EPS accretion, but entails increased leverage approaching a 2.0x ratio.
Despite operational progress, investors appeared concerned about the cautious outlook and financial commitments associated with the acquisition, leading to the significant share price decline.

View recap

ABB Ltd

ABBN.SW Q2 2026

Reported: 2026-07-18

Shares fell 4.8% as investors were disappointed by a pronounced order decline in the Automation segment, despite record overall orders and revenues. The tough comparable base and cautious segment outlook weighed on sentiment.

Key takeaways

Group orders reached a record $12 billion for the quarter, up 28% year-over-year, driven by strong demand in Electrification (+58%) and Motion (+20%).
The Automation business area saw an order decline, negatively impacting overall group order growth for the quarter.
Management highlighted ongoing strong market environments across segments but noted the Automation segment’s order weakness against a difficult comparable.
ABB reiterated its acquisition strategy with a planned Rotork deal expected to enhance automation capabilities and margin profile in the medium term.
Strong cash flow and margin improvements supported earnings, yet concerns around segment deceleration and cautious near-term outlook dominated investor focus.

View recap

Abbott Laboratories

ABT Q2 2026

Reported: 2026-07-18

Abbott delivered better-than-expected sales growth and raised its EPS guidance, driving a strong 12.8% stock gain as durable demand across key segments and pipeline progress reassured investors.

Key takeaways

Reported 4.8% comparable sales growth in Q2, accelerating from the prior two quarters.
Adjusted EPS of $1.31 came above the midpoint of guidance, prompting an EPS outlook raise to $5.45–$5.60 for 2026.
Diagnostics showed mixed results: core laboratory US business grew 7.5%, cancer diagnostics climbed 13%, but rapid and molecular diagnostics declined 8% due to a weak respiratory testing season.
Nutrition sales improved sequentially by $125 million, with international pediatric nutrition growing 6.5% and U.S. adult nutrition volumes increasing double digits post-price adjustments.
Pipeline progress remains strong, with multiple product launches and clinical trial enrollments planned in the next 12 months, supporting future growth potential.

View recap

Atlas Copco AB

ATCO-A.ST Q2 2026

Reported: 2026-07-18

Atlas Copco’s shares rose 4.6% following Q2 results, driven by a broad-based beat in order intake and organic growth across all business areas and regions, notably strong growth in semiconductor and Gas and Process compressors segments.

Key takeaways

Orders received grew 26% organically year-over-year, adding more than SEK 10 billion to the order book.
Revenue increased 8% organically, supported by strong volumes in Vacuum Technique and broad-based growth across all business areas.
Adjusted profit rose 12% year-on-year with a stable profit margin of 21% and sequential margin improvement.
Cash flow remained solid despite inventory and receivable buildup related to production ramp-up.
Geographic growth was robust, with North America (+49%) and Asia (+47%) leading, while the Middle East showed weakness due to delayed customer spending.

View recap

General Electric Company

GE Q2 2026

Reported: 2026-07-18

Shares tumbled 3.2% following the report due to a cautious outlook that tempered enthusiasm despite solid operational execution and order growth.

Key takeaways

Orders rose 17% in Q2, contributing to a robust backlog exceeding $210 billion.
Revenue increased 24%, driven by a 27% jump in Commercial Engines & Services (CES) and 16% in Defense & Power Technologies (DPT).
Operating profit grew 18%, while EPS increased 22%, supported by strong free cash flow growth of 43% and a conversion rate over 140%.
Leadership highlighted FLIGHT DECK improvements that significantly reduced production lead times and enhanced supplier efficiency.
Despite operational momentum and higher guidance, investor reaction suggests concerns about growth sustainability or margin pressure implied in the cautious outlook.

View recap

Intuitive Surgical, Inc.

ISRG Q2 2026

Reported: 2026-07-18

Shares dropped 11.2% as investors reacted negatively to signs of US procedural growth deceleration and an increasingly cautious outlook amid persistent challenges in China’s market and pricing pressures.

Key takeaways

US da Vinci procedure growth slowed to 12%, below prior trends, with moderation mainly in deferrable procedures, linked to patient coverage and premium changes.
China remains a challenging market due to reduced tender activity, domestic competition, and policy-driven pricing pressure.
Global installed base expanded, with 468 da Vinci systems and 55 ION systems placed, alongside consistent 16% growth in total procedures.
Single port (SP) procedures surged 61%, supported by adoption in Korea and the US and new product enhancements.
Management projects cost reduction via extended use of select instruments to expand adoption, particularly in cost-sensitive markets, but these initiatives may pressure near-term margins.

View recap

Nordea Bank Abp

NDA-FI.HE Q2 2026

Reported: 2026-07-18

Nordea’s shares edged up modestly by 0.9% after reporting a quarter with stable costs and improving net interest income, but the muted market response suggests investors remain cautious on the outlook despite solid fee income growth and asset expansion.

Key takeaways

Return on equity was a healthy 15.9%, with earnings per share up 3% year-on-year to EUR 0.36.
Total income increased 4% to over EUR 3 billion, supported by an 11% rise in net fee and commission income.
Assets under management surged 16% to a record EUR 505 billion, driven by strong demand for savings and investment products.
Net interest income grew 1% quarter-on-quarter but remains down 1% year-on-year; net interest margin slightly contracted to 1.54%.
Costs were flat year-on-year excluding currency effects, resulting in improved jaws with income growing faster than expenses.

View recap

Netflix, Inc.

NFLX Q2 2026

Reported: 2026-07-18

Netflix shares dropped 6.4% following Q2 earnings as investors reacted negatively to a modest deceleration in revenue growth guidance and subtle signs of margin pressure, reflecting concerns over slower topline momentum and cautious near-term outlook despite sustained full-year targets.

Key takeaways

Q3 revenue growth guidance was lowered to 11% FX-neutral from 12% in Q2, signaling a slight deceleration that disappointed the market.
Management emphasized long-term growth and reiterated 13%-14% full-year revenue growth, but the quarter-to-quarter slowdown raised investor caution.
Content spend is increasing about 10% in 2026, moderately above recent averages, indicating ongoing investment but with careful cost control to moderate margin impact.
Viewing hours per member showed modest growth (2% in H1 2026), but management acknowledged this metric’s limitations and focused on engagement quality and variety as more critical.
Despite management’s optimism on market penetration and addressable revenue opportunities, the lack of stronger near-term upside and evolving content economics weighed on sentiment.

View recap

Publicis Groupe S.A.

PUB.PA Q2 2026

Reported: 2026-07-18

Shares of Publicis Groupe declined 1.1% post-earnings, reflecting investor caution despite raised guidance, as ongoing weakness in the technology segment and geopolitical headwinds tempered enthusiasm.

Key takeaways

Q2 net organic growth accelerated slightly to +4.8%, driven primarily by marketing transformation services growing 6.5% organically.
Connected Media (62% of revenue) expanded at high single-digit rates, supported by double-digit growth in Europe and solid U.S. performance.
Intelligent Creativity grew in low double digits, consistent with its long-term growth profile.
Publicis Sapient (13% of revenue) declined mid-single digits due to macroeconomic uncertainty and delays in large transformation programs, notably in the Gulf region.
Geographically, strong growth in the U.S. (+5.5%) and Europe (+5%), but offset partially by EMEA decline (-8.3%) amid geopolitical tensions.

View recap

State Street Corporation

STT Q2 2026

Reported: 2026-07-18

Shares fell 2.2% after earnings as investors likely tempered enthusiasm despite record revenue and broad momentum, possibly due to cautious outlook signals or lingering concerns over margin sustainability.

Key takeaways

Record quarterly revenue increased 17% year over year, driven by highest-ever fee, servicing, management, FX trading revenues, and net interest income.
EPS rose to $3.65 from $2.17 year over year, marking a 44% increase excluding prior notable items.
State Street reports 10 consecutive quarters of positive operating leverage, reflecting disciplined execution.
Strong client engagement advanced digital asset initiatives, including planned tokenized fund servicing and strategic partnerships for active co-branded ETFs.
Despite operational progress and a 10% dividend increase, the modest stock decline suggests investors may question the sustainability of margins or remain cautious on medium-term guidance.

View recap

Telenor ASA

TEL.OL Q2 2026

Reported: 2026-07-18

Telenor’s shares fell 7.4% after the Q2 report as investors reacted negatively to the lowered full-year outlook amid declining EBITDA, margin pressure in Norway, and ongoing transformation costs, signaling that underlying challenges and cautious guidance overshadowed the quarter’s modest revenue growth.

Key takeaways

Service revenues declined 0.7% year-over-year, with underlying comparable service revenues improving slightly by 0.3%.
Adjusted EBITDA dropped 4.8% reported, and by 2.3% on a fully comparable basis, reflecting margin compression primarily in Norway.
Norway faced particularly tough comparables, promotional market pressure, and a one-time VAT provision, resulting in a 2% EBITDA decline despite 0.6% revenue growth.
Transformation programs increased short-term OpEx due to dual IT costs and platform migrations, with significant cost savings expected only from 2027 onwards.
Full-year guidance was revised downward due to the challenging operating environment and transformation-related expenses, outweighing positives in Sweden, Denmark, and IoT partnerships.

View recap

Tanzanian Gold Corporation

TRX Q3 2026

Reported: 2026-07-18

TRX Gold’s shares declined 2.9% despite meeting production guidance, reflecting investor caution around modest margin pressures and slower capital deployment. While the company confirmed ongoing expansion and exploration plans, the market appears unimpressed by incremental progress against the backdrop of persistently subdued multiples.

Key takeaways

Produced approximately 28,000 ounces over the last 12 months, in line with guidance of 25,000 to 30,000 ounces for the year.
Generated $115 million in revenue and $66.8 million in adjusted EBITDA for the last twelve months, supporting internal funding for expansion.
Invested nearly $47-$48 million over the past year in working capital and CapEx, with future focus transitioning primarily to CapEx and exploration.
Mill expansion to increase throughput above prior 3,000 tpd capacity is underway, with an updated PEA expected in Q4 2026 potentially enhancing NAV.
Management highlighted healthy margins and low-cost operation, but acknowledged recent market-driven compression of EBITDA multiples amid lower gold prices.

View recap

UnitedHealth Group Incorporated

UNH Q2 2026

Reported: 2026-07-18

UnitedHealth Group’s shares rose modestly by 1.8% following mixed results: Medicare Advantage performed better than expected with improved margins and membership retention, but persistent commercial cost pressures and margin headwinds limited investor enthusiasm.

Key takeaways

Medicare Advantage enrollment now expected to decline by ~1.1 million in 2026, with margins forecasted to finish above 3%, reflecting effective benefit design and care management efforts.
Medicare medical cost trends, while elevated, are running below initial expectations (~10%) due to internal initiatives and favorable external factors.
Commercial medical cost trends remain stubbornly high, modestly exceeding 11%, driven by independent resolution process impacts and higher provider billing intensity.
Medicaid performance was broadly in line with expectations but margins remain pressured as reimbursement rates lag medical cost trends.
Optum businesses are tracking in line with plans, with momentum building in Optum Health and ongoing reinvestment at Optum Insight focused on AI-enabled modernization.

View recap

U.S. Bancorp

USB Q2 2026

Reported: 2026-07-18

U.S. Bancorp reported broadly in line results with modest revenue growth and positive operating leverage, while the market reaction was flat (+0.2%), reflecting balanced takeaways from the quarter without significant surprises.

Key takeaways

Earnings per share rose 22% year-over-year to $1.35, supported by 10.1% revenue growth to a record $7.7 billion.
Fee income accelerated, reaching 44% of total revenue, bolstered by the BTIG acquisition, which contributed $98 million in its first month.
Loan growth was broad-based, with average loans up 7.1% year-over-year, driven by C&I, credit card, and commercial real estate segments.
Operating efficiency improved, with the efficiency ratio down to 57.1% and positive operating leverage of 400 basis points.
Credit quality remained stable with improving metrics, while consumer deposits hit another record, supported by the Bank Smartly product suite.

View recap

Earnings Recaps

Alcoa Corporation

ABB Ltd

Abbott Laboratories

Atlas Copco AB

General Electric Company

Intuitive Surgical, Inc.

Nordea Bank Abp

Netflix, Inc.

Publicis Groupe S.A.

State Street Corporation

Telenor ASA

Tanzanian Gold Corporation

UnitedHealth Group Incorporated

U.S. Bancorp

Community

Earnings Recaps

Alcoa Corporation

ABB Ltd

Abbott Laboratories

Atlas Copco AB

General Electric Company

Intuitive Surgical, Inc.

Nordea Bank Abp

Netflix, Inc.

Publicis Groupe S.A.

State Street Corporation

Telenor ASA

Tanzanian Gold Corporation

UnitedHealth Group Incorporated

U.S. Bancorp

Community

Trending This Week

Notifications